Overview
Rare cancers account for 20 per cent of cancers diagnosed in Australia, and 30 per cent of cancer-related deaths. People with rare cancers are more likely to die from their disease than people with more common cancers.
The outlook for people with rare cancers is not as good as that for people with more common cancers because:
- Rare cancers are often diagnosed at late, more advanced and harder to treat stages, because there are no effective screening strategies For patients and their health professionals may not recognise the symptoms of rare cancers
- Treatments for many rare cancers have not advanced at the same pace as treatments for more common cancers in recent years. This is because it is much harder to research or perform clinical trials for rarer diseases and there is often less support for researchers or clinicians.
The COSA Rare Cancers Group was established to help support and improve outcomes for patients with rare cancers. We work with community support groups such as Rare Cancers Australia (rarecancers.org.au) and the Cancer Council's Rare and Less Common Cancers Working Group.
We take an Australia-wide and international approach as collaborations are vital to more rapidly develop rare cancer knowledge and provide the most robust evidence-based for rare cancer patients.
Our membership is open to allied health and medical practitioners, and cancer researchers, with an interest in rare cancers. We also work with other tumour stream specialty groups to promote and develop rare cancer trials and research.
Group information
Read the Rare Cancers Group Terms of Reference
Read the AGM Minutes from 7 December 2020
What’s the latest
Group Chair
Group Chair
Clare Scott
Rare Cancers Group Chair & ANZGOG Representative
Join Australia's leading oncology community & make an impact
Become a COSA memberTwitter
@COSAoncology
Follow
COSAoncology 1 hours ago
RT @M_Jefford: Our correspondence, #OpenAccess in @JCO_ASCO today 🚨 shared care for #cancersurvivors is preferred by pts, cheaper for the h…
Read More >COSAoncology 3 hours ago
RT @cancer_K2A: Another big day of great presentations at #WICC2024 If you’re interested in learning how #survonc & supportive care can im…
Read More >COSAoncology 4 hours ago
Join or renew your COSA membership before 30 April 2024 to get bonus months of membership and a saving! https://t.co/KyH4eMpIOp https://t.co/8fIetrPa2t
Read More >COSAoncology 21 hours ago
RT @DrNicolasHart: A very warm welcome to our new @COSA_Surviv Executive Members from diverse multidisciplinary backgrounds and geographica…
Read More >COSAoncology yesterday
Join COSA, the national multidisciplinary community for health care professionals working in cancer care. Get involved and make a difference in cancer care through collaboration, research, advocacy and education: https://t.co/KyH4eMpIOp https://t.co/OWpl9WPYhW
Read More >COSAoncology yesterday
Huge respect and love for @MargaretMcJann1 from the COSA membership as she winds up her years of service to #ANZUP and the broader cancer healthcare community!
Read More >COSAoncology 4 days ago
COSA is the national oncology community bringing together multidisciplinary health professionals across all cancers to advance care and improve outcomes. More on member benefits here: https://t.co/4Fw9lbNDrf https://t.co/QUk49A5jvO
Read More >COSAoncology 6 days ago
It only takes a few minutes to join COSA – Plus, join before 30 April 2024 and not only get bonus months of membership, but also save on member rates before prices increase for 2024! Join now: https://t.co/KyH4eMpIOp https://t.co/YuKeOsmq7k
Read More >COSAoncology 7 days ago
RT @rayychan: My absolute pleasure to support 2 stars @CancerCareMASCC to develop new knowledge re international barriers towards implement…
Read More >COSAoncology 7 days ago
RT @HyunKoMD: Great team effort of the multidisciplinary team, esp Profs Grace Kong and Michael Michael! Looking forward to delivering con…
Read More >